<DOC>
	<DOCNO>NCT01705210</DOCNO>
	<brief_summary>The exact neuronal mechanism underlie cognitive decline associate diabetes mellitus type 2 ( DM2 ) still remain elucidated . Multi-parametric functional MRI potentially provide functional , micro-structural , micro-vascular , metabolic information affect brain earlier stage conventional structural MRI . The overall aim current proposal obtain good understand neuronal mechanism underlie cognitive decline DM2 putative prediabetic condition metabolic syndrome ( MetS ) .</brief_summary>
	<brief_title>Functional MRI Biomarkers Cognitive Decrements Diabetes</brief_title>
	<detailed_description>Diabetes mellitus type 2 ( DM2 ) common chronic metabolic disorder affect 4.1 % Dutch population . In addition vascular disease , DM2 associate structural brain change visible MRI , accelerate cognitive decline , dementia old individual . The exact pathophysiological mechanism underlie cognitive decrement DM2 still remain elucidated . The 'metabolic syndrome ' ( MetS ) , define cluster cardiovascular risk factor ( include obesity , hypertension , dyslipidemia ) often consider prediabetic condition . Individuals MetS display similar cognitive decrement DM2 patient , share severity brain injury . It indicate prediabetic MetS , cognitive problem precede structural brain change , MetS DM2 affect brain share mechanism vascular co-morbidity essential . The primary objective define accord hierarchical design : ) tailor apply multi-parametric , functional MRI technique identify cerebral abnormality ( cerebral biomarkers ) DM2 MetS ; ii ) investigate cerebral biomarkers share differ DM2 MetS ; iii ) ass whether cerebral biomarkers associate cognitive decrement .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Mild Cognitive Impairment</mesh_term>
	<criteria>Inclusion criterion : Subjects age 4075 year Subjects enrolled exist 'Maastricht Study ' ( MStudy ) Subjects give write consent approach additional research Subjects belong 20 % worst 20 % best performing ( base neuropsychological cognitive testing ( Stroop colorword test , 15 word learn test , Delayed recall recognition 15 word learn test ) Individuals Diabetes type 2 : Fasting blood glucose ≥ 7.0 mmol/l , oral glucose tolerance test ( OGTT ) blood glucose ≥ 11.1 mmol/l use oral glucoselowering medication insulin Metabolic syndrome : Participants meet three 5 follow criterion [ 8 ] : 1 . Waist circumference &gt; 88 cm ( woman ) , &gt; 102 cm ( men ) 2 . Triglycerides ≥ 1.7 mmol/l 3 . HDL cholesterol &lt; 1.3 mmol/l ( woman ) , &lt; 1.0 mmol/l ( men ) 4 . Blood pressure ≥ 130/85 mmHg ( medication ) 5 . Fasting blood glucose ≥ 6.1 mmol/l , OGTT blood glucose ≥ 7.8 mmol/l Control participant : Those fulfil 1 criterium metabolic syndrome , DM2 . Exclusion criterion : Contraindications MRI examination ( e.g . pacemaker ; neurostimulator ; medication pump ; cochlear hearing implant ; tattoo item remove include metal part ( instance operation past ) ; metal splinter eye ; pregnancy claustrophobia ; brain vessel clamp ; denture , contain magnet ) . Psychiatric comorbidity inability perform functional MRI test . Incomplete cognitive assessment data Diabetes mellitus type 1 ( DM1 ) Subjects belong 20 % worst 20 % best performing individual ( base neuropsychological cognitive testing ( Stroop colorword test , 15 word learn test , Delayed recall recognition 15 word learn test ) . Last visit subject MStudy le one year</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>